ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 results. The results, out after market close yesterday evening, came more than a month after the FDA approved Eli Lilly’s GLP-1 drug Zepbound (tirzepatide) as the first and only prescription drug to treat sleep apnea. CMS […]
Respiratory
AerWave completes first-in-human study of lung denervation tech
AerWave announced today that it completed the first-in-human feasibility study of its disease-modifying ultrasound lung denervation therapy. New York-based AerWave also raised $12 million to further advance its therapy for chronic obstructive pulmonary disease (COPD) and asthma. The ultrasound platform aims to simplify and enhance lung denervation, according to a news release. It eliminates the […]
Lungpacer Medical wins FDA premarket approval for AeroPace neurostim system
Lungpacer Medical announced that it received FDA premarket approval for its flagship AeroPace neurostimulation system. AeroPace uses neurostimulation via an electrode-containing cardiovascular catheter and a software-controlled system. It delivers periodic phrenic nerve stimulation through the venous catheter. The system contracts and strengthens the diaphragm in patients on mechanical ventilation. Exton, Pennsylvania–based Lungpacer’s system received an […]
CorVent wins FDA clearance for Respond critical care ventilator
CorVent Medical announced today that it received FDA 510(k) clearance for its Respond critical care ventilator system. The company designed Respond as a cost-effective option to deliver simple, safe and smart ventilation. It aims to expand access to quality care for healthcare systems, providers and patients. Respond, a lightweight, easy-to-use ventilator, combines elements of traditional […]
Philips updates use instructions for several ventilators following recalls
The FDA issued a notice updating instructions for a number of ventilators made by Philips (NYSE:PHG) Respironics. This recall involves updating instructions for devices, not removing them from use or sale. The FDA identified the recall as the most serious kind, as it may cause serious injury or death. It relates to an October warning […]
Philips to pay $25M to monitor people affected by CPAPs recall
A federal judge recently approved Philips paying $25 million to monitor and research the affects of its major respiratory devices recall. The monitoring will occur over the next 15 years, according to the settlement approved Oct. 31 by U.S. District Judge Joy Flowers Conti in western Pennsylvania. Conti is overseeing all federal lawsuits involving the […]
LivaNova nerve stim for sleep apnea meets primary study endpoints
LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints. OSPREY evaluates targeted hypoglossal nerve stimulation in the treatment of obstructive sleep apnea. With its safety endpoints, the trial achieved statistical significance in its primary endpoint responder rates between the treatment arm and the sham arm […]
Inspire Medical enters into $75M share repurchase program
Inspire Medical Systems (NYSE:INSP) announced today that it entered into an accelerated share repurchase program worth $75 million. Minneapolis-based Inspire entered into the repurchase agreement with Goldman Sachs. It’s being completed pursuant to a previously announced $150 million share repurchase program authorized by the Inspire board. Inspire scheduled the termination of the accelerated share repurchase […]
Inspire Medical sales grow more than 30% in Street-beating Q3, full-year guidance raised
Inspire Medical Systems (NYSE:INSP) shares are up today on third-quarter results that came in ahead of the consensus forecast. Shares of INSP were up more than 3% to $199.42 apiece by the afternoon today. Yesterday evening, the Minneapolis-based developer of neurostimulation technology for treating sleep apnea reported profits of $18.5 million. That equals 60¢ per […]
Electromed appoints VP of marketing
Electromed today announced it appointed Peter Horwich as VP of marketing. “We are excited to have Peter Horwich join our team at a time of business growth, where we can leverage his talents for further market expansion,” said Jim Cunniff, Chief Executive Officer. “The Vice President, Marketing is a strategic role for Electromed that will […]
ResMed stock ticks up on Street-beating Q1
ResMed (NYSE:RMD) shares are on the rise today on first-quarter results that came in ahead of the consensus forecast on Wall Street. Shares of RMD ticked up 4.4% to $249.51 apiece in pre-market trading today. The San Diego–based sleep respiratory technology company reported profits of $311.4 million. That equals $2.11 per share on sales of […]